We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-9 of 9

FDA to Announce Public Hearing Concerning its Approach to Evaluating the Safety and Efficacy of Nicotine Replacement Therapy (NRT) Products and Formation of a Nicotine Steering Committee
  • Keller and Heckman LLP
  • USA
  • November 29 2017

In tomorrow's Federal Register, the FDA will announce a public hearing concerning FDA's approach to evaluating the safety and efficacy of nicotine

Other cases of interest
  • Borden Ladner Gervais LLP
  • Canada
  • April 27 2010

The Patented Medicine Prices Review Board (PMPRB) released its decision, finding that Nicoderm had not been sold at an excessive price.

Can I refuse to hire a smoker?
  • Borden Ladner Gervais LLP
  • Canada
  • November 3 2009

Society is becoming increasingly intolerant of smokers.

Pharmaceutical, pulp mill mergers cleared subject to conditions
  • Squire Patton Boggs
  • European Union
  • January 22 2007

The Commission has approved the acquisition of Pfizer's consumer healthcare business by J&J, subject to conditions.

Adam M. Susser
  • Keller and Heckman LLP

Azim Chowdhury
  • Keller and Heckman LLP